CIK 0001488039 · Non-accelerated filer<br>Smaller reporting company
ATOSSA THERAPEUTICS, INC.
Sign in to watch- Ticker
- ATOS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 264753208
- Phone
- 206.588.0256
- Business address
- 1448 NW MARKET STREET, SUITE 500, SEATTLE, WA, 98107
- Former names
- ATOSSA GENETICS INC
- 424B5 Offering Prospectus
- 8-K Event Other events
- 424B5 Offering Prospectus
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change
- 424B3 Offering Prospectus
- 8-K Event Material agreement · Regulation FD disclosure · Other events
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- EFFECT Other Notice of Effectiveness
- 4 Open-market buy Director bought 10,000 shares at $2.58 ($25,785)
- S-3 Offering Registration Statement
- S-1 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
- 4 Grant or award Director acquired 24,510 shares (grant or award)
Page 27 of 33 · 643 filings